MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Mar 26, 2025
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-03-24$0.92/sh+500,000$460,000→ 1,750,210 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-03-24−500,000→ 0 totalExercise: $0.92From: 2015-04-02Exp: 2025-04-02→ Common Stock (500,000 underlying) - Tax Payment
Common Stock
2025-03-24$9.63/sh−282,497$2,720,446→ 1,467,713 total
Footnotes (1)
- [F1]Represents a "net exercise" of outstanding stock options, which options were scheduled to expire on April 2, 2025. The reporting person received 217,503 shares of common stock on net exercise of an option to purchase 500,000 shares of common stock. The Company withheld 282,497 shares of common stock underlying the option as consideration for the exercise price and tax withholdings, using the average of the high and low sales price on March 24, 2025 of $9.63, pursuant to the terms of the Company's 2007 Stock Option Plan.